Picture of Biorestorative Therapies logo

BRTX — Biorestorative Therapies News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Brief: BioRestorative Therapies Announces SBIR Phase I Grant To Explore The Therapeutic Effects Of ThermoStem Targeting Polycystic Ovary Syndrome As Indication

Dec 6 (Reuters) - BioRestorative Therapies Inc  BRTX.O :
    * BIORESTORATIVE THERAPIES ANNOUNCES SBIR PHASE I GRANT TO
EXPLORE
THE THERAPEUTIC EFFECTS OF THERMOSTEM® TARGETING POLYCYSTIC
OVARY SYNDROME AS AN INDICATION

Source text for Eikon:  ID:nGNX6N5dZ8 
Further company coverage:  BRTX.O

Recent news on Biorestorative Therapies

See all news